1 rical experience with the three-times-weekly dosage schedule.

2 th wild-type cells and treated with the same dosage schedule.

3            In our analysis, we used multiple dosage schedules and incorporated interactions among can

4                                     The oral dosage schedule of 2 g of valacyclovir TID reaches acycl

5  no treatment, DMSO, or NGP1-01 (dosages and dosage schedule same as above).

6                                 Four vaccine dosage schedules were tested sequentially, all of which